Eliem Therapeutics, Inc.
Achat netELYM·US·🇺🇸 US
68%achats·32%ventes
293 transactions$635.0MTotal achats·44 achats
$3.5MTotal ventes·21 ventes
3030 insiders
Dernier : 12 déc. 2025
| Date | Insider | Type | Valeur | |
|---|---|---|---|---|
| 12 déc.+3j | RA Capital Nexus Fund II, L.P.BOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 12 déc.+3j | RA Capital Biotech Fund LPBOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 12 déc.+3j | RA Capital Nexus Fund, L.P.BOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 12 déc.+3j | RA CAPITAL MANAGEMENT, LLCBOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 12 déc.+3j | RA Capital Nexus Fund III, L.P.BOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 12 déc.+3j | Shah Rajeev M.BOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 12 déc.+3j | Kolchinsky PeterBOARD MEMBER·Common Stock· ind. | Achat | $290K | |
| 11 déc.+4j | RA Capital Nexus Fund II, L.P.BOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | RA Capital Biotech Fund LPBOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | RA Capital Nexus Fund, L.P.BOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | RA CAPITAL MANAGEMENT, LLCBOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | RA Capital Nexus Fund III, L.P.BOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | Shah Rajeev M.BOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | Kolchinsky PeterBOARD MEMBER·Pre-Funded Warrants (Right to Buy)· ind. | Attribution | - | |
| 11 déc.+4j | RA Capital Nexus Fund II, L.P.BOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | RA Capital Biotech Fund LPBOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | RA Capital Nexus Fund, L.P.BOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | RA CAPITAL MANAGEMENT, LLCBOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | RA Capital Nexus Fund III, L.P.BOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | Shah Rajeev M.BOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | Kolchinsky PeterBOARD MEMBER·Common Stock· ind. | Cession | - | |
| 11 déc.+4j | RA Capital Nexus Fund II, L.P.BOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 11 déc.+4j | RA Capital Biotech Fund LPBOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 11 déc.+4j | RA Capital Nexus Fund, L.P.BOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 11 déc.+4j | RA CAPITAL MANAGEMENT, LLCBOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 11 déc.+4j | RA Capital Nexus Fund III, L.P.BOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 11 déc.+4j | Shah Rajeev M.BOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 11 déc.+4j | Kolchinsky PeterBOARD MEMBER·Common Stock· ind. | Achat | $465K | |
| 1 oct.· | ALTSCHULLER SusanCFO·Stock Option (Right to Buy) | Attribution | - | |
| 7 août+4j | Thomas Stephen BasilBOARD MEMBER·Common Stock | Attribution | - |